tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY

Alnylam Pharma (ALNY) Revenue

Compare
1,245 Followers

Alnylam Pharma Revenue

Alnylam Pharma had a revenue of 594.19M in the quarter ending Mar 31, 2025, with 0.17%. This bring the company's revenue in the last twelve months to 2.35B, Decreased 4.44%. In the fiscal year ending Dec 31, 2024, Alnylam Pharma had annual revenue of 2.25B with 22.97% growth.
Revenue (ttm)
2.35B
Revenue Growth
17.21%
P/S Ratio
17.45
Revenue/Employee
$1,008,181
Employees
2,230
Market Cap
$39.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.25B419.95M+22.97%
Dec 31, 2023
1.83B790.87M+76.23%
Dec 31, 2022
1.04B193.13M+22.88%
Dec 31, 2021
844.29M351.43M+71.31%
Dec 31, 2020
492.85M273.10M+124.28%
Dec 31, 2019
219.75M144.84M+193.36%
Dec 31, 2018
74.91M-15.00M-16.69%
Dec 31, 2017
89.91M42.75M+90.66%
Dec 31, 2016
47.16M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis